Insider Purchases: Inside the Buy
Tag: InsiderBuying
New CEO Buys In at Dave & Buster’s ($PLAY). Who Doesn’t Like a Little PLAY in Their Portfolio — or Life?
New CEO Tarun Lal takes the reins—and a big slice of $PLAY stock. With insiders buying, institutions overloaded, and sales trends improving, could this be the next comeback classic of the “entertainment” era?
Simmons Bank: Insider Buys, 116 Years of Dividends, and a Footlong Public Offering
Simmons Bank has paid dividends for over a century—and insiders just went on a buying spree. 📉 Stock’s dipped, 🔍 valuation isn’t screaming cheap, but with improving net income and institutional support, SFNC might be worth a second look. If not exciting, at least it’s… dependable?
Can Elevance Reach Higher Elevations? The CEO Thinks So
📉 After falling nearly 50% from its highs, Elevance Health just got a $2.4M vote of confidence from its CEO. Is this the cure—or just another symptom? 🏥 Dive into the numbers, the risks, and the potential rewards. And yes, there will be icons. 📊💊📈
Helen of Troy (HELE) — Insider Buys, CFOs Turned CEOs, and a Falling Knife You Might Want to Catch (Carefully)
The CEO and CFO of Helen of Troy just bought shares as the stock plunges 90%. Are we looking at a tragic tale, or a comeback for the ages? We dig into the numbers, leadership shuffle, and Wall Street signals—with humor and historical flair.
Healthpeak Properties (DOC): Insiders Are Buying—Should You?
📈 Healthpeak Properties (DOC) insiders are buying—and not just a little. But with a forward P/E north of 70 and a few post-merger integration challenges, is this stock still a hidden gem or more of a polished maybe? Dive in for the full take.
PVH: Fashion. Fundamentals. CEO Buying. Doesn't the $500M Share Buyback Scream Deep Value?
CEO Stefan Larsson just bought $1M worth of PVH stock—and he’s not alone. With iconic brands like Calvin Klein and Tommy Hilfiger, institutional support over 100%, and a massive share buyback underway, PVH may be a classic turnaround play. But is it fashionably early… or just fashionably risky?
Insiders Are Buying ConocoPhillips. Should You?
Insiders are drilling into COP shares—and they're not alone. With a $10B return plan, strong reserves, and a smart buyout of Marathon Oil, ConocoPhillips might just be the contrarian pick of the year. Here's the fun, smart breakdown.
Oxford Industries’s Tommy Bahama and Lilly Pulitzer Rock: Should You Emulate Insiders and Buy More Than the Brands?
Oxford Industries owns some of the most recognizable lifestyle brands—Tommy Bahama, Lilly Pulitzer, and Johnny Was. Sales are soft, but margins hold, insiders are buying, and the dividend is sweet. Time to sip a piña colada—and check the stock price?
Moderna: Messenger RNA Medicines Powerhouse Sends A New Message — “Discount!”
Insiders dropped $6M on Moderna stock. With a massive mRNA pipeline and deep-pocketed backers, is this biotech beast ready to roar again?
CEO Bought Shares: Is Full House Worth Betting the House?
Full House Resorts is growing fast—but still bleeding cash. The CEO’s massive insider buy may hint at a turnaround, but with debt looming and expansion plans on the table, is FLL worth a gamble? We break it down—odds, icons, and all.